Quince Therapeutics (QNCX) Insider Trading & Ownership → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free QNCX Stock Alerts $0.90 -0.01 (-1.62%) (As of 05:45 PM ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Quince Therapeutics (NASDAQ:QNCX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.80%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$648,111.20Number OfInsiders Selling(Last 12 Months)0 Get QNCX Insider Trade Alerts Want to know when executives and insiders are buying or selling Quince Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address QNCX Insider Buying and Selling by Quarter Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Quince Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/14/2023David LamondDirectorBuy22,627$1.04$23,532.08 12/12/2023David LamondDirectorBuy22,327$1.02$22,773.54 12/7/2023David LamondDirectorBuy19,123$1.01$19,314.23 12/5/2023David LamondDirectorBuy19,123$1.01$19,314.23 12/1/2023David LamondDirectorBuy14,378$0.94$13,515.32 11/29/2023David LamondDirectorBuy14,378$0.98$14,090.44 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/30/2023David LamondDirectorBuy41,026$1.31$53,744.06 8/17/2023David LamondDirectorBuy24,766$1.29$31,948.14 8/15/2023David LamondDirectorBuy107,886$1.32$142,409.52 8/10/2023Dirk ThyeCEOBuy88,000$1.26$110,880.00 8/8/2023Brendan HannahInsiderBuy71,762$1.22$87,549.64 8/8/2023Dirk ThyeCEOBuy80,000$1.24$99,200.00 8/8/2023Margaret McloughlinDirectorBuy8,000$1.23$9,840.00 (Data available from 1/1/2013 forward) QNCX Insider Trading Activity - Frequently Asked Questions Who is on Quince Therapeutics's Insider Roster? The list of insiders at Quince Therapeutics includes Brendan Hannah, David Lamond, Dirk Thye, Margaret Mcloughlin, and Ted Monohon. Learn more on insiders at QNCX. What percentage of Quince Therapeutics stock is owned by insiders? 16.80% of Quince Therapeutics stock is owned by insiders. Learn more on QNCX's insider holdings. Which Quince Therapeutics insiders have been buying company stock? The following insiders have purchased QNCX shares in the last 24 months: Brendan Hannah ($87,549.64), David Lamond ($340,641.56), Dirk Thye ($210,080.00), and Margaret Mcloughlin ($9,840.00). How much insider buying is happening at Quince Therapeutics? Insiders have purchased a total of 533,396 QNCX shares in the last 24 months for a total of $648,111.20 bought. Which Quince Therapeutics insiders have been selling company stock? The following insider sold QNCX shares in the last 24 months: Ted Monohon ($1,833.58). How much insider selling is happening at Quince Therapeutics? Insiders have sold a total of 1,871 Quince Therapeutics shares in the last 24 months for a total of $1,833.58 sold. More Insider Trading Tools from MarketBeat Related Companies: OKYO Insider Transactions DYAI Insider Transactions SABS Insider Transactions CYTH Insider Transactions INAB Insider Transactions TARA Insider Transactions INKT Insider Transactions SRZN Insider Transactions PLUR Insider Transactions NKGN Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:QNCX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Nvidia WarningAltimetryA ‘DeFi Summer’ Projected!Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe #1 Investment of the Decade… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.